Human Immunodeficiency Virus (HIV)
Information about activities and policies related to HIV
FDA approved changes to the DOVATO (dolutegravir/lamivudine) product labeling to include a new indication and provide longer term safety and efficacy data
Get the latest update in HIV news
More HIV News
Sub-Topic Paragraphs
NAVIGATE THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) SECTION
About HIV and the Center for Drug Evaluation and Research's role
Learn what HIV is and how CDER is working to prevent and treat HIV infections
HIV Treatment
Get information about drugs approved to treat HIV
Subscribe to Learn What’s New in HIV at CDER
Get regular FDA email updates on HIV delivered to your inbox